ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -57 مورد

Incidence of breast cancer-related lymphedema

Incidence of breast cancer-related lymphedema
Treatment Five-year incidence of BCRL*[1] Five-year incidence of BCRL¶[2]
ALND + RLNR 30.1% Not reported
ALND 24.9% 23%Δ
SLNB + RLNR 10.7% Not reported
SLNB 8.0% 11%

ALND: axillary lymph node dissection; BCRL: breast cancer-related lymphedema; RLNR: regional lymph node radiation; SLNB: sentinel lymph node biopsy.

* Relative volume change ≥10% from preoperative baseline.

¶ Clinical sign in the ipsilateral arm.

Δ ALND with or without RLNR (RLNR is performed when ALND revealed ≥4 positive nodes).
Data from:
  1. Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: Long-term results from a prospective screening trial. J Clin Oncol 2020; 38:3430.
  2. Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 2014; 15:1303.
Graphic 139998 Version 1.0